ZA200809096B - Salts and crystal modifications thereof - Google Patents

Salts and crystal modifications thereof

Info

Publication number
ZA200809096B
ZA200809096B ZA200809096A ZA200809096A ZA200809096B ZA 200809096 B ZA200809096 B ZA 200809096B ZA 200809096 A ZA200809096 A ZA 200809096A ZA 200809096 A ZA200809096 A ZA 200809096A ZA 200809096 B ZA200809096 B ZA 200809096B
Authority
ZA
South Africa
Prior art keywords
salts
crystal modifications
crystal
modifications
Prior art date
Application number
ZA200809096A
Other languages
English (en)
Inventor
Feng Lili
Jiang Xinglong
Karpinski Piotr
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA200809096B publication Critical patent/ZA200809096B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200809096A 2006-05-23 2008-10-23 Salts and crystal modifications thereof ZA200809096B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80283606P 2006-05-23 2006-05-23

Publications (1)

Publication Number Publication Date
ZA200809096B true ZA200809096B (en) 2009-11-25

Family

ID=38704747

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200809096A ZA200809096B (en) 2006-05-23 2008-10-23 Salts and crystal modifications thereof

Country Status (28)

Country Link
US (1) US7977330B2 (fr)
EP (1) EP2029556B1 (fr)
JP (2) JP2009538330A (fr)
KR (1) KR20090009898A (fr)
CN (1) CN101448796B (fr)
AR (1) AR061056A1 (fr)
AT (1) ATE486858T1 (fr)
AU (1) AU2007267671A1 (fr)
BR (1) BRPI0712556A2 (fr)
CA (1) CA2650514A1 (fr)
CL (1) CL2007001454A1 (fr)
CR (1) CR10431A (fr)
DE (1) DE602007010286D1 (fr)
EC (1) ECSP088900A (fr)
ES (1) ES2355166T3 (fr)
GT (1) GT200800253A (fr)
IL (1) IL195008A0 (fr)
MA (1) MA30482B1 (fr)
MX (1) MX2008014836A (fr)
NO (1) NO20085000L (fr)
PE (1) PE20080261A1 (fr)
PL (1) PL2029556T3 (fr)
PT (1) PT2029556E (fr)
RU (1) RU2008150627A (fr)
TN (1) TNSN08477A1 (fr)
TW (1) TW200815375A (fr)
WO (1) WO2007140154A2 (fr)
ZA (1) ZA200809096B (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05002871A (es) 2002-09-20 2005-10-05 Arrow Therapeutics Ltd Derivados de benzodiazaepina y composiciones farmaceuticas que los contienen.

Also Published As

Publication number Publication date
CR10431A (es) 2009-01-07
US20090163478A1 (en) 2009-06-25
US7977330B2 (en) 2011-07-12
WO2007140154A2 (fr) 2007-12-06
MX2008014836A (es) 2008-12-01
PE20080261A1 (es) 2008-04-18
ECSP088900A (es) 2008-12-30
IL195008A0 (en) 2009-08-03
EP2029556B1 (fr) 2010-11-03
MA30482B1 (fr) 2009-06-01
AR061056A1 (es) 2008-07-30
PL2029556T3 (pl) 2011-04-29
CL2007001454A1 (es) 2008-05-16
RU2008150627A (ru) 2010-06-27
BRPI0712556A2 (pt) 2013-07-02
JP2013075910A (ja) 2013-04-25
KR20090009898A (ko) 2009-01-23
ATE486858T1 (de) 2010-11-15
AU2007267671A1 (en) 2007-12-06
TNSN08477A1 (en) 2010-04-14
JP2009538330A (ja) 2009-11-05
DE602007010286D1 (de) 2010-12-16
ES2355166T3 (es) 2011-03-23
PT2029556E (pt) 2011-01-31
CN101448796B (zh) 2012-09-26
TW200815375A (en) 2008-04-01
GT200800253A (es) 2009-04-29
NO20085000L (no) 2008-12-23
WO2007140154A3 (fr) 2008-03-20
EP2029556A2 (fr) 2009-03-04
CN101448796A (zh) 2009-06-03
CA2650514A1 (fr) 2007-12-06

Similar Documents

Publication Publication Date Title
TWI561237B (en) Substituted dihydropyrazolones and their use
EP2009469A4 (fr) Element de traitement d'image et affichage
EP2185692A4 (fr) Hco32 et hco27 et exemples connexes
HK1208000A1 (en) Thioninium compounds and their use
EP2001590A4 (fr) Sels de polyimidazolium et complexes poly-nhc-metal
HK1133552A1 (en) Carboranylporphyrins and uses thereof
GB0611115D0 (en) Compounds and their use
EP2006352A4 (fr) Composition de cristaux liquides et element a cristaux liquides
HK1102977A1 (en) Reversible timepiece
TWI346220B (en) Lcd
EP2069371A4 (fr) Composés d'organo-arsénoxydes et leur utilisation
GB2451789B (en) Reminder device
GB0622479D0 (en) Novel salts and their therapeutic use
IL195529A0 (en) New crystal forms
GB0611136D0 (en) Crystal structure
GB0619611D0 (en) Compounds and their use
GB0615934D0 (en) Crystal structure
IL195008A0 (en) Salts and crystal modifications thereof
GB0600406D0 (en) Crystal
GB0617237D0 (en) Crystal structure
GB0617306D0 (en) An amine and its salts
GB0614427D0 (en) Reminder device
GB0614680D0 (en) Reminder Device
GB0618523D0 (en) M O R crystal P
GB0621665D0 (en) Blogmail and podmail